Jamie Kang

[Autoimmunity Reviews] Scientists highlighted the important role of the mucus layer in inflammatory bowel disease (IBD) and the therapies that target the mucus layer in IBD.

[NewScientist] More and more people under 50 have been diagnosed with bowel cancer in different parts of the world over the past few decades.

[New England Journal of Medicine] In a Phase III, open-label trial, scientists enrolled patients with estrogen-receptor-positive, human epidermal growth factor receptor 2–negative advanced breast cancer that recurred or progressed during or after aromatase inhibitor therapy, administered alone or with a cyclin-dependent kinase 4 and 6 inhibitor.

[Colloids and Surfaces B-Biointerfaces] A doxorubicin-loaded injectable hydrogel based on hyaluronic acid was fabricated for locoregional chemotherapy and inhibiting the metastasis of breast cancer.

[Eterna Therapeutics] Eterna Therapeutics announced it will investigate the ability of its lead induced pluripotent stem cell-derived mesenchymal stem cells-based cell therapy to induce and modulate antitumor immunity in ovarian cancer and breast cancer models through a sponsored research agreement with The University of Texas MD Anderson Cancer Center.

[TheScientist] Researchers tweak heart-forming organoids to produce blood cells, in a process that mimics embryonic development.